Figure Legend
Figure: Effective redeployment of existing medicines requires explicit consideration of indication-specific factors relating to differences in potency, plasma and tissue pharmacokinetics (PK), safety, formulation, posology and barriers to equitable deployment across relevant populations and country contexts.